Kaushal, K. et al. 2026. Real-World Evaluation of Trastuzumab Emtansine Biosimilar in Early-Stage HER2-Positive Breast Cancer: Results from a Single-Center Retrospective Study in India: Real-world outcomes of T-DM1 biosimilar. Archives of Breast Cancer. 13, 2 (Apr. 2026), 182–189. DOI:https://doi.org/10.32768/abc.2906718345-529.